Purchase Order 75N93024P00793

Award Date 6/28/24
Potential Completion Date 8/2/24
Potential Value $64K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $303,590.36 firm fixed price purchase order contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Sanaria Inc., a for-profit organization and veteran-owned business that manufactures goods. The contract is for a 24-month malaria culture service to provide asexual malaria blood stage cultures and enriched late-stage gametocyte cultures to support malaria drug development efforts. This award is not associated...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $298,596 definitive contract to Sanaria Inc. of Potomac, MD for Research Type Small Business Innovation Research Program Phase I Action. The contract is a firm fixed price award with a period of performance from August 30, 2022 through April 1, 2024. The place of performance is Potomac, MD and the contract has a total small business set aside...
This is a $3,397,349.60 fixed-price level of effort contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery to Sanaria Inc., a veteran-owned biotechnology company, for a Phase III clinical trial of an investigational malaria vaccine. The contract is for the production and delivery of Plasmodium falciparum sporozoites, the parasite that causes malaria, to support the clinical trial. Sanaria Inc. has previously provided services to the National Institutes of Health and...
This is a $2,399,997.00 federal contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Sanaria Inc., a for-profit, veteran-owned biotechnology company that manufactures goods. The contract is for research and development services, including providing asexual malaria blood culture service and conducting phase III clinical trials for an investigational malaria vaccine involving Plasmodium falciparum sporozoites. Sanaria Inc. has also received grants from the National...
This is a $999,997.00 firm fixed-price SBIR Phase II R&D contract awarded by the Defense Health Agency (DHA) to Sanaria Inc., a small business veteran-owned manufacturer. The contract is for the "Delivery System for Cryopreserved Eukaryotic Cell Vaccines," supporting Sanaria's work on an investigational malaria vaccine using Plasmodium falciparum sporozoites. Sanaria has previously received federal funding for malaria vaccine research, development, and manufacturing from agencies...
The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $40,505 firm-fixed-price purchase order to Charles River Laboratories, Inc. to perform characterization testing of Pichia master and working cell banks. This work supports ongoing research at the Laboratory of Malaria Immunology and Vaccinology to develop a malaria transmission-blocking vaccine candidate. The testing will demonstrate the identity, purity,...
This is a federal research and development contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Sanaria Inc., a biotechnology company, for the development of a multi-strain malaria vaccine. The contract has a total potential value of $2,799,216.00 and is a definitive contract with a cost-no-fee pricing type. The contract does not have a set-aside designation and is set to be completed by July 18, 2019. Sanaria Inc. has previously provided services to support malaria...
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $87,170.00 firm-fixed-price purchase order to Dataworks Development, Inc., a woman-owned small business manufacturer based in Mountlake Terrace, Washington. The contract is for the provision of two licenses of the Freezerworks 2018: Pinnacle Edition, Windows Server software, which will be used to support ongoing malaria vaccine research at NIAID's Laboratory of Malaria...
This is a $5,699,486.00 federal contract award from the Bureau of Medicine and Surgery, a defense agency, to Sanaria Inc., a for-profit, veteran-owned business and manufacturer. The contract is for research and development services, with a performance period ending on October 31, 2018. Sanaria Inc. has provided services such as asexual malaria blood culture, clinical trial services for an investigational malaria vaccine, and research and development of P. falciparum sporozoite vaccines. This...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $89,054.88 firm fixed price purchase order to Sanaria Inc. to provide asexual malaria blood culture service. The contract calls for monthly delivery of Plasmodium falciparum asexual parasites at over 90% ring stage, complete culture medium, and human blood for use in the National Center for Translational Sciences' malaria viability assays to support...

The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $64,000.00 firm fixed price purchase order contract to Sanaria Inc., a biotechnology company that specializes in malaria vaccine development. The contract is for the procurement of Sanaria's PfSPZ Reagent biological kits, which will be used for ongoing clinical trial experiments at the Laboratory of Immunogenetics (LIG) to study immune interactions with peripheral blood mononuclear cells (PBMCs) collected during recent trials. This sole source contract was awarded on a non-set-aside basis under the authority of FAR 13.106-1, as NIAID determined that changing variables within the clinical trial would compromise the data and findings. Sanaria Inc., located in Rockville, MD, is the only responsible source for these specific kits.

Generated 7/3/24, 9:03 AM